Critical Insights From Sangamo Therapeutics Analyst Ratings: What You Need To Know
Critical Insights From Sangamo Therapeutics Analyst Ratings: What You Need To Know
來自Sangamo Therapeutics分析師評級的關鍵見解：你需要知道的
In the preceding three months, 4 analysts have released ratings for Sangamo Therapeutics (NASDAQ:SGMO), presenting a wide array of perspectives from bullish to bearish.
在過去的三個月中，有4位分析師公佈了Sangamo Therapeutics（納斯達克股票代碼：SGMO）的評級，提出了從看漲到看跌的各種觀點。
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
下表概述了他們最近的評級，簡要介紹了過去30天中不斷變化的情緒，並將其與前幾個月進行了比較。
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $3.75, a high estimate of $5.00, and a low estimate of $2.00. Marking an increase of 25.0%, the current average surpasses the previous average price target of $3.00.
分析師評估的12個月目標股價揭示了進一步的見解，平均目標價爲3.75美元，最高估計爲5.00美元，低估值爲2.00美元。當前的平均價格上漲了25.0％，超過了之前的平均目標股價3.00美元。
Analyzing Analyst Ratings: A Detailed Breakdown
分析分析師評級：詳細明細
In examining recent analyst actions, we gain...
在研究分析師最...
登入免費觀看全文
登入/註冊